Kleiner Perkins led a $130m funding round in NewLimit.

Kleiner Perkins, a venture capital firm, led a $130m funding round in NewLimit, a biotechnology company, with participation from Nat Friedman, Daniel Gross, Khosla Ventures, Human Capital, Valor Equity Partners, Dimension, Founders Fund and Brian Armstrong. “What the AI model allows us to do is run all those experiments in simulation and then only follow up on the most promising subset," Jacob Kimmel, NewLimit Founder.